机构:UNIV LONDON, CHARING CROSS & WESTMINSTER MED SCH, ACAD UNIT NEUROSCI, LONDON, ENGLAND
HERING, R
ROSE, FC
论文数: 0引用数: 0
h-index: 0
机构:UNIV LONDON, CHARING CROSS & WESTMINSTER MED SCH, ACAD UNIT NEUROSCI, LONDON, ENGLAND
ROSE, FC
机构:
[1] UNIV LONDON, CHARING CROSS & WESTMINSTER MED SCH, ACAD UNIT NEUROSCI, LONDON, ENGLAND
[2] LONDON NEUROL CTR, LONDON, ENGLAND
来源:
HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH
|
1992年
/
3卷
/
01期
关键词:
D O I:
暂无
中图分类号:
Q189 [神经科学];
学科分类号:
071006 ;
摘要:
Migraine headaches are more common in females than males. Two-thirds of women implicate the menstrual cycle as a factor conditioning their migraine attacks. Many women experience migraine with increased frequency and intensity at times of hormonal change: menstruation; ovulation; the first trimester of pregnancy, and the early postpartum period. Moreover, oral contraceptive medication and replacement estrogen therapy may increase the incidence of migraine headache. The best available preventive treatment consists of cyclic percutaneous administration of estradiol. This treatment is the only one that prevents migraine attacks and preserves the hormonal cycle.
机构:
Univ London, City London Migraine Clin, London EC1M 6DX, England
Univ London, Queen Marys Sch Med & Dent, Ctr Res Neurosci, Inst Cell & Mol Sci, London, EnglandUniv London, City London Migraine Clin, London EC1M 6DX, England